Patents by Inventor Kevin Hrusovsky

Kevin Hrusovsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quantification of neurofilament light chain in physiological samples
    Patent number: 12287343
    Abstract: The present disclosure relates to immunoassays for NF-L performed on liquid samples derived from physiological fluids such as venous blood to detect the presence or absence of a physiological condition by quantifying one or a combination of NF-L determinations at concentrations indicative of the condition.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: April 29, 2025
    Assignee: QUANTERIX CORPORATION
    Inventors: Edward Kevin Hrusovsky, David Wilson, Dandan Shan, Lei Chang, Linan Song, Andreas Jeromin, Carmen Ioana Tobos, Purvish Prahlad Patel
  • Quantification of biomarkers present in physiological samples
    Patent number: 12130294
    Abstract: The present disclosure relates to immunoassays for NF-L, GFAP, UCH L1, and Tau performed on liquid samples derived from physiological fluids such as venous blood to detect the presence or absence of a physiological condition by quantifying one or a combination of NF-L, GFAP, UCH L1, and Tau at concentrations indicative of the condition.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: October 29, 2024
    Assignee: QUANTERIX CORPORATION
    Inventors: Edward Kevin Hrusovsky, David Wilson, Dandan Shan, Lei Chang, Linan Song, Andreas Jeromin, Carmen Ioana Tobos, Purvish Prahlad Patel
  • Quantification of biomarkers present in dried physiological samples
    Patent number: 12111324
    Abstract: The present disclosure relates to digital immunoassays performed on diluted samples obtained from dried blood spots, for example dried capillary blood samples, to detect the presence or absence of a physiological condition by quantifying one or a combination of biomarkers at concentrations indicative of the condition.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: October 8, 2024
    Assignee: QUANTERIX CORPORATION
    Inventors: Edward Kevin Hrusovsky, David Wilson, Dandan Shan, Lei Chang, Linan Song, Andreas Jeromin, Carmen Ioana Tobos, Purvish Prahlad Patel
  • METHODS AND KITS FOR DETECTING SARS-CORONAVIRUS-2 ANTIGEN
    Publication number: 20220050106
    Abstract: The present disclosure relates to methods and compositions, e.g., kits, for assessing or detecting SARS-CoV-2 antigen(s), e.g., SARS-CoV-2 nucleocapsid protein (N-protein), in a sample or a blood sample, e.g., serum, plasma, dried blood spots (DBS) and/or a saliva sample. Certain applications and uses of the present methods and compositions, e.g., kits, are also provided.
    Type: Application
    Filed: August 11, 2021
    Publication date: February 17, 2022
    Applicant: Quanterix Corporation
    Inventors: Andrew Ball, Lei Chang, Syrena Fernandes, Kevin Hrusovsky, Joseph Johnson, Dawn Mattoon, Tatiana Plavina, Dandan Shan, David Wilson